Merck stops trial for potential blood thinner

WHITEHOUSE STATION, N.J. (AP) -- Shares of Merck & Co. are falling after the drugmaker says it has halted one late-stage trial of a potential blood thinner and will immediately stop giving the drug in another study to patients who have had a stroke....

Read the whole article on AP Health

More from AP Health